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Protease inhibitors (PIs) and hemagglutinins are defense proteins produced by many organisms. From Chinese mini-black
soybeans, a 17.5-kDa PI was isolated using chromatography on Q-Sepharose, SP-Sepharose, and DEAE-cellulose. A 25-kDa
hemagglutinin was puriﬁed similarly, but using Superdex 75 instead of DEAE-cellulose in the ﬁnal step. The PI inhibited trypsin
andchymotrypsin (IC50 =7.2 and8.8μM).Its trypsin inhibitoryactivity wasstablefrompH2 topH 13andfrom0◦Ct o70
◦C.The
hemagglutinin activity of the hemagglutinin was stable from pH 2 to pH 13 and from 0◦Ct o7 5
◦C. The results indicated that both
PI and hemagglutinin were relatively thermostable and pH-stable. The trypsin inhibitory activity was inhibited by dithiothreitol,
signifying the importance of the disulﬁde bond to the activity. The hemagglutinating activity was inhibited most potently by D
(+)-raﬃnose and N-acetyl-D-galactosamine, suggesting that the hemagglutinin was speciﬁc for these two sugars. Both PI and
hemagglutinin inhibited HIV-1 reverse transcriptase (IC50 = 3.2 and 5.5μM), proliferation of breast cancer cells (IC50 = 9.7 and
3.5μM), and hepatoma cells (IC50 = 35 and 6.2μM), with relatively high potencies.
1.Introduction
Defense proteins including protease inhibitors are produced
by a variety of organisms including animals [1]a n dp l a n t s
[2–16]. Plants produce an array of defense proteins to
combat noxious pathogens and predators. These defense
proteins constitute a heterogeneous repertoire that com-
prises protease inhibitors [1–16], hemagglutinins [17], anti-
fungal proteins [18], and ribosome inactivating proteins
[19]. The defense proteins exert a diversity of actions such
as immunomodulatory, antitumor/antiproliferative, and
antiviral activities [2,13–16].Among theprotease inhibitors,
trypsin inhibitors represent a frequently studied group.
Hemagglutinins are also a subject of intensive investigation.
The seeds of leguminous plants are abundant in proteins
which may include some of the aforementioned defense
proteins. The mini-black cultivar of soybean (Glycine soja)
has not been examined previously. An extract of this bean
exhibits protease inhibitory and hemagglutinating activities.
Since diﬀerent cultivars of the same species may produce
diﬀerent proteins, we undertook the present study to isolate
and characterize a protease inhibitor and a hemagglutinin
from the mini-black soybean.
Soybean has many beneﬁcial eﬀects and can ameliorate
some diseases [20–22]. An aqueous extract of soybean
Glycine max exerted a signiﬁcant antihyperglycemic action
in alloxan-induced diabetic mice [23]. Using monocyte/
macrophage-like cell models [24], it has been demonstrated
that a combination of avocado/soybean unsaponiﬁables and
chondroitin sulfate can inhibit cytokine (TNF-α and IL-1β)
expression and prostaglandin E2 production. Osteoarthritis
is characterized by inﬂammation and elevated produc-
tion of proinﬂammatory mediators such as cytokines and
prostaglandin E2. Macrophage-like cells in synovial tissue
produce these mediators which induce cartilage-degrading
enzymes. Hence, it is possible to make use of soybeans to
inhibit osteoarthritis.
Black soybean has long been used in Chinese traditional
medicine, as a detoxiﬁer, an anti-inﬂammatory drug and a
blood nutrient and for promoting urination. It suppresses
the growth of transplantable human bladder carcinoma
and tumor angiogenesis in mice [25], exhibits antioxidant2 Evidence-Based Complementary and Alternative Medicine
activity, inhibits low density lipoprotein oxidation [26], and
can be used for treating an ophthalmic disorder associated
with retinal pigment epithelium disturbance [27]. The
polysaccharides prepared from black soybeans [28]c a n
also be used to stimulate cellular immunity by augmenting
the production of cytokines and in preventing or treating
leukemia. It is beneﬁcial to the health of patients who
have been infected by pathogens such as HIV, by elevat-
ing the blood cell number and enhancing the immune
system [29]. Black soybean is more eﬀective than yellow
soybean in preventing menopausal symptoms. Ovariec-
tomized menopausal rats fed on black soybeans demon-
strated a signiﬁcantly greater reduction in blood-cholesterol
concentration, compared to rats fed on yellow soybeans.
Consumption of black soybeans protects against bone loss
in ovariectomized rats by inhibiting bone turnover and
bone resorption [30]. Black soybean peptides when applied
in vivo and in vitro reduce endoplasmic reticulum stress
and improve insulin resistance [31], whilst anthocyanins
from black soybean seed coats stimulate wound healing
in ﬁbroblasts and keratinocytes and prevent inﬂammation
in endothelial cells [32]. They preferentially inhibit tumor
necrosis factor-alpha-mediated induction of vascular cell
adhesion molecule-1 over intercellular adhesion molecule-
1 through the regulation of transcription factor genes
binding to DNA sequence GATA and interferon regulatory
transcription factor-1 [33]. The anthocyanins inhibit UVB-
induced inﬂammatory cylooxygenase-2 gene expression and
PGE2 production through regulation of the nuclear factor-
kappaBand phosphatidylinositol 3-kinase/Aktpathway[34].
They also exert hypolipidemic and antiobesity actions [35].
Red soybean anthocyanins demonstrate an antitumor action
[36].
Since black soybean has medicinal properties and its
activities are reportedly more potent than those of yellow
soybean, we undertook the present study to isolate a
hemagglutinin and a protease inhibitor with antitumor and
HIV-1 reverse transcriptase inhibitory activities from mini-
black soybean which is a special type of black soybean.
2.Materialsand Methods
2.1. Materials. Chinese mini-black soybeans (Glycine sojacv.
“Mini-black Soybean”) from China (100g) were deposited
in laboratory 302, School of Biomedical Sciences, The
Chinese University of Hong Kong (CUHK) under voucher
number LB302, after authentication by Professor Shiuying
Hu, Honorary Professor of Chinese Medicine, CUHK. SP-
Sepharose,Q-Sepharose, and Superdex75 HR10/30columns
and Puriﬁer were bought from GE Healthcare (Hong Kong).
DEAE-cellulose, Trizma base (98% purity), NaCl (99%
purity), and NH4OAc (98% purity) were obtained from
Sigma Chemical Co., St. Louis, Missouri, USA.
2.2. Isolation of Protease Inhibitor and Hemagglutinin. The
beans were extracted with distilled water (10mL/g) at room
temperature in a Waring blenderfor 10 minutes, followed by
centrifugation at 13000g and 4◦Cf o r3 0m i n u t e s .T r i s - H C l
buﬀer (pH 7.4, 1M) was added to the resulting supernatant
until the ﬁnal concentration of Tris attained 20mM. The
supernatant was then loaded on a 5cm × 20cm column
of Q-Sepharose in 20mM Tris-HCl buﬀer (pH 7.4). After
removal of unabsorbed proteins, the column was elutedwith
0.2M NaCl added to the Tris-HCl buﬀer. The fraction eluted
with 0.2M NaCl was dialyzed extensively against distilled
water, and 1M NH4OAc buﬀer (pH 4.5) was added until the
NH4OAc concentration reached 100mM. This was followed
by ion exchange chromatography on a 2.5cm × 30cm
column of SP-Sepharose in the same buﬀer. After removal
of unabsorbed proteins, the column was eluted with a linear
0–0.5M NaCl gradient (total volume 650mL) added to the
NH4OAc buﬀer. The protease inhibitor-enriched fraction
SP1 was eluted with the 0–0.25M NaCl gradient, and the
hemagglutinin-enriched fraction SP3 was eluted with the
0.175–0.5M NaCl gradient. Both fractions were dialyzed
extensively against distilled water at 4◦C overnight. In the
case of the protease inhibitor-enriched fraction, the Tris
concentration of the fraction was adjusted to 20mM. This
was followed by ion exchange chromatography on a 2.5cm
× 30cm column of DEAE-cellulose in 20mM Tris-HCl
buﬀer (pH 7.4). After removal of unabsorbed proteins, the
columnwaselutedsequentiallywitha0–0.5MNaClgradient
(totalvolume480mL)addedtotheTris-HCl buﬀer.Fraction
D2, which was eluted with a 0.31–0.44M NaCl gradient,
was dialyzed against distilled water. D2 represented puriﬁed
black soybean protease inhibitor. Hemagglutinin-enriched
fraction SP3 was subjected to FPLC (fast protein liquid
chromatography)-gel ﬁltration on a Superdex 75 HR10/30
column using an AKTA Puriﬁer.
2.3. Electrophoresis, Molecular Mass Determination, and N-
terminal Amino Acid Sequence Analysis. The puriﬁed pro-
tease inhibitor/hemagglutinin was subjected to sodium
dodecyl sulfate-polyacrylamide gel electrophoresis (SDS-
PAGE) for molecular mass determination. After elec-
trophoresis, the gel was stained with Coomassie Brilliant
Blue. The molecular mass of the isolated protein was
determined by comparison of its electrophoretic mobility
w i t ht h o s eo fm o l e c u l a rm a s sm a r k e rp r o t e i n sf r o mG E
H e a l t h c a r e .G e lﬁ l t r a t i o no na nF P L C - S u p e r d e x7 5c o l u m n ,
which had been calibrated with molecular mass markers (GE
Healthcare),wasconductedtodeterminethemolecularmass
of the protein. The N-terminal sequence of the protein was
determined by using a Hewlett-Packard HP G1000A Edman
degradation unit and a HP 1000 HPLC System.
2.4. Trypsin-Inhibitory and Chymotrypsin-Inhibitory Activ-
ities of Isolated Protease Inhibitor. Trypsin activity was
determined by using casein from Sigma as substrate [35].
The assay for trypsin-inhibitory activity was carried out by
addition of the test sample to 160μL of a 1% casein solution
in 0.1M Tris-HCl buﬀer(pH 7.4). Bovine pancreatic trypsin
from Sigma (20μL of a 0.5mg/mL solution) was then added
and the mixture was incubated at37◦Cfor 15 minutes before
0.4mL 5% (w/v) trichloroacetic acid was added to terminate
the reaction. After centrifugation, the absorbance of theEvidence-Based Complementary and Alternative Medicine 3
supernatant, which reﬂects the amount of casein fragments,
was measured at 280nm.
The isolated trypsin inhibitor (2.4μM) was incubated
with dithiothreitol (DTT) from Sigma, at ﬁnal concentra-
tions of 6mM, 32mM, and 64mM for 25min at 37◦C. For
comparison, soybean trypsin inhibitor (Sigma) (2.88μM)
was similarly treated. The reaction was terminated by adding
iodoacetamide at twice the amount of thiol functions con-
tained in each DTT concentration. The remaining trypsin-
inhibitory activity was measured at pH 8 as described above.
The highest iodoacetamide concentration used in the test
was devoid of any eﬀect on the activity of trypsin and the
trypsin-inhibitory activity of the isolated trypsin inhibitor
and soybean trypsin inhibitor [8].
Chymotrypsin activity was determined by using N-α-
benzoyl-L-tyrosyl ethyl ester hydrochloride (BTEE) from
Sigma as substrate and bovine pancreatic chymotrypsin
(USB Corporation, Ohio, USA) [12]. When BTEE was used
as substrate, 25μL of a serial concentration of puriﬁed
trypsin inhibitor was incubated with 25μLc h y m o t r y p s i n
(1mg/mL in 50mM Tris-HCl containing 0.2M CaCl2,p H
7.6) for 5min at 37◦C. The residual chymotrypsin activity
was measured by adding 1.45mL 0.25mM N-α-benzoyl-L-
arginine ethyl ester (BAEE) as substrate. After immediate
mixing by inversion the increase in A253 was recorded for
5min. Reactions without addition of test samples were used
as positive control.
2.5. Hemagglutinating Activity of Isolated Hemagglutinin.
Fifty microliters of a serial two-fold dilution of the hemag-
glutinin solution in a microtiter U-plate were mixed with
50μL of a 2% suspension of rabbit red blood cells in
phosphate-buﬀered saline (pH 7.2) at 20◦C. The results were
read after about 1h, when the blank had fully sedimented.
One hemagglutination unit is deﬁned as the reciprocal of the
highest dilution exhibiting hemagglutination whilst speciﬁc
activity is the number of hemagglutination units/mg protein
[37].
Serial twofold dilutions of sugar (melibiose, L-arabinose,
D(+)-glucosamine, glucuronic acid, D(+)-xylose, D-galac-
turonic acid, α-lactose, D(+)-raﬃnose, mannitol, D(+)-
galactose, D-glucose, D(+)-fucose, N-acetyl-D-galactosam-
ine, D(+)-mannose, alpha-methyl-D-glucoside, D-galacton-
ic acid, maltose, D-L-rhamnose, and xylitol from Sigma)
samples were prepared in phosphate buﬀered saline (PBS).
All of the dilutions were mixed with an equal volume (25μL)
of a solution of the hemagglutinin with 3 hemagglutination
units. The mixture was allowed to stand for 30min at room
temperature and then mixed with 50μL of a 2% rabbit
erythrocyte suspension. The minimum concentration of
the sugar in the ﬁnal reaction mixture, which completely
inhibited 3 hemagglutination units of the hemagglutinin
preparation, was calculated [37].
2.6. Thermostability of Hemagglutinin and Protease Inhibitor.
The hemagglutinin samples and trypsin inhibitor samples
were kept separately at diﬀerent temperatures (10◦Ct o
100◦C, at 10◦C intervals) for 30min. The hemagglutinating
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Figure 1:(a) Ionexchange chromatographyona SP-Sepharosecol-
umn (2.5cm × 30cm). Sample: fraction of the mini-black soybean
extract adsorbed on Q-Sepharose and subsequently eluted by 0.2M
NaCl in 20mM Tris-HCl buﬀer. The dotted slanting line represents
the linear NaCl concentration gradient (0–0.5M) in 100mM
NH4OAc buﬀer (pH 4.5) used to elute the absorbed proteins from
the column. Unabsorbed proteins eluted with 100mM NH4OAc
buﬀer (pH 4.5) are not shown. Hemagglutinating activity was
observed in fraction SP3. Trypsin-inhibitory activity was found in
fraction SP1. Fraction size: 13mL, ﬂow rate: 30mL/h. Conc. Of
NaCl (M---), and absorbance at 280nm (•). The vertical lines
in the elution proﬁle denote the pooling of eluate into SP1, SP2,
and SP3. (b) Ion exchange chromatography on a DEAE-cellulose
column (2.5cm × 30cm). Sample: Fraction SP1, the ﬁrst adsorbed
fraction from SP-Sepharose. Adsorbed proteins were eluted from
the column by using a linear NaCl concentration gradient (0–
0.5M)in20mMT ris-HClbuﬀer(pH7.4)represented bythedotted
slanting line across the chromatogram. Trypsin-inhibitory activity
was observed only in fraction D2. Unabsorbed proteins eluted with
20mM Tris-HCl buﬀer (pH 7.4) are not shown. Fraction size:
6mL, ﬂow rate: 30mL/h, Conc of NaCl (M---), and absorbance
at 280nm (•).
activity andtrypsin-inhibitory activity weredeterminedafter
returning to room temperature [37–40].
2.7. pH Stability of Hemagglutinin. The hemagglutinin sam-
ples were kept separately at diﬀerent pH values (2 to 13)
for 30min. After the pH had been adjusted to pH 7, the
hemagglutinating activity was determined [37–40].4 Evidence-Based Complementary and Alternative Medicine
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Figure2:Standardcurveforthemolecularweightdeterminationof
the puriﬁed protease inhibitor and hemagglutinin from mini-black
soybean using Superdex 75HR 10/30 chromatography on Superdex
75HR 10/30.
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Figure 3: Results of SDS-PAGE after staining with Coomassie
Brilliant Blue. Left lane: markers from GE Healthcare including
phosphorylase b (94-kDa), bovine serum albumin (67-kDa), oval-
bumin (43-kDa), carbonic anhydrase (30-kDa), soybean trypsin
inhibitor (20-kDa), and α-lactalbumin (14.4-kDa). Middle lane:
fraction D2 with trypsin-inhibitory activity from DEAE-cellulose
column chromatography representing puriﬁed protease inhibitor.
Right lane: fraction S1 from Superdex 75 column representing
puriﬁed mini-black soybean hemagglutinin.
2.8. Antiproliferative Activity of Isolated Protease Inhibitor
and Hemagglutinin on Tumor Cell Lines. Breast cancer
(MCF-7) cells and hepatoma (HepG2) cells from American
Type Tissue Collection were suspended in RPMI medium
containing 10% fetal bovine serum, 100U/mL penicillin,
and 100μg/mL streptomycin (Gibco) and adjusted to a
cell density of 2 × 104 cells/mL. A 100μL aliquot of this
cell suspension was seeded to a well of a 96-well plate,
followed by incubation for 24 hours. Diﬀerent concentra-
tions of the protease inhibitor or hemagglutinin in 100μL
complete RPMI medium were then added to the wells and
incubated for 72 hours at 37◦C. After 72 hours, 20μL
Unabsorbed
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Unabsorbed
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Absorbed fractions eluted with
0–0.5M NaCl gradient
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Distilled water
Aqueous extract
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SP1
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SP2
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SP3
fraction
DEAE
cellulose
D2
fraction
Trypsin
inhibitor
Superdex
75
Hemagglutinin
SP-Sepharose
Figure 4: Flow chart summarizing the procedure used for isolating
protease inhibitor and hemagglutinin from mini-black soybean.
of a 5mg/mL solution of (3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide)(MTT) in phosphate buﬀered
saline wasspikedintoeachwellandtheplateswereincubated
for 4 hours. The plates were then centrifuged at 324×gf o r5
minutes. The supernatant was carefully removed, and 150μL
of dimethyl sulfoxide was added in each well to dissolve
the MTT-formazan at the bottom of the wells. After 10
minutes, the absorbance at 590nm was measured by using a
microplate reader [18]. The defensin-like antifungal peptide
sesquin from the bean Vigna sesquipedalis [18] was used as a
positive control. Green lentil trypsin inhibitor [9]w a su s e d
as a negative control in the assay.
2.9. Ability of Isolated Protease Inhibitor and Hemagglutinin
to Inhibit HIV-1 Reverse Transcriptase Inhibitory Activity.
The assay for ability to inhibit HIV reverse transcriptase
inhibitory activity was carried out according to instructions
supplied with the assay kit from Boehringer Mannheim
(Germany). The assay takes advantage of the ability of
reverse transcriptase to synthesize DNA, starting from
the template/primer hybrid poly (A) oligo (dT) 15. The
digoxigenin- and biotin-labeled nucleotides in an optimized
ratio are incorporated into the DNA molecule, which is
freshly synthesized by the reverse transcriptase (RT). The
detection and quantiﬁcation of synthesized DNA as aEvidence-Based Complementary and Alternative Medicine 5
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Figure 5: (a) Determination of IC50 values of trypsin- and
chymotrypsin-inhibitory activities of mini-black soybean protease
inhibitor (MBSTI) and soybean trypsin inhibitor (STI). Results are
means ± SD (n = 3). The protease inhibitor was incubated with
bovine pancreatic trypsin andcasein(forassayoftrypsin inhibitory
activity) or with N-α-benzoyl-L-tyrosyl ethyl ester hydrochloride
(for assay of chymotrypsin inhibitory activity) and bovine pan-
creatic chymotrypsin for 15 minutes in 0.1M Tris-HCl buﬀer
(pH 7.4) before addition of 5% trichloroacetic acid. The reaction
mixture was centrifuged and OD280 of the supernatant containing
the tryptic fragments of casein was read. Background values
were determined and subtracted before % inhibition values were
calculated. Datapoints bearing thesameletter represent statistically
signiﬁcant diﬀerence (P<. 05) when the data were analyzed by
ANOVA followed by Duncan’s multiple range test. (b) Eﬀect of
dithiothreitol (DTT) on trypsin-inhibitory activity of 2.4μM mini-
black soybean (MBSPI) and 2.8μM trypsin inhibitor from soybean
(STI) after incubation at 37◦C for 25 minutes. Results are means ±
SD(n = 3).TheIC50 ofDTTwasabout30mMonMBSPIandlower
than10mMonSTI.Theproteaseinhibitor(1.8mM)wasincubated
with dithiothreitol at various concentrations before termination
of reaction with iodoacetamide and determination of remaining
trypsin-inhibitoryactivity.Backgroundvaluesweredeterminedand
subtracted before % inhibition values were calculated. Data points
bearing the same letter represent statistically signiﬁcant diﬀerence
(P<. 05) when the data were analyzed by ANOVA followed by
Duncan’s multiple range test.
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Figure 6:Inhibitory eﬀect ofmini-blacksoybean proteaseinhibitor
(
￿) and hemagglutinin (•) on HIV-1 reverse transcriptase activity.
Results are means ± SD (n = 3). The inhibitory activities
were determined with an ELISA kit from Boehringer Mannheim.
Background values were determined and subtracted before %
inhibition values were calculated. Data points bearing the same
letter represent statisticallysigniﬁcantdiﬀerence (P<. 05)when the
data were analyzedby ANOVAfollowedby Duncan’s multiplerange
test.
parameter for RT activity follow a sandwich ELISA protocol.
Biotin-labeled DNA binds to the surface of microtiter plate
modules that have been precoated with streptavidin. In
the next step, an antibody to digoxigenin, conjugated to
peroxidase, binds to the digoxigenin-labeled DNA. In the
ﬁnal step, the peroxidase substrate is added. The peroxidase
enzyme catalyzes the cleavage of the substrate, producing a
colored reaction product. The absorbance of the sample at
405nm can be determined using a microtiter plate (ELISA)
reader and is directly correlated to the level of RT activity.
A ﬁxed amount (4–6ng) of recombinant HIV-1 reverse
transcriptase wasused.Theinhibitoryactivityoftheprotease
inhibitor/hemagglutinin was calculated as percent inhibition
compared with the control without the protein [18]. The
leguminous defensin-like protein sesquin was used as a
positive control [18] and the antifungal protein mungin [41]
as a negative control.
2.10. Antifungal Activity of Isolated Hemagglutinin and Pro-
tease Inhibitor. The assay of the isolated protease inhibitor/
hemagglutinin for antifungal activity toward Botrytiscinerea,
Mycosphaerella arachidicola,a n dFusarium oxysporum,whic h
are plant pathogens, was carried out using 90 × 15mm
petri plates containing 10mL of potato dextrose agar. After
the mycelial colony had developed, sterile blank paper disks
(0.625cm in diameter) were placed at a distance of 0.5cm
away from the rim of the mycelial colony. An aliquot of a
solution of the protease inhibitor/hemagglutinin was added
to a disk. After the plates had been incubated at 25◦Cf o r7 2
hours, mycelial growth had enveloped disks containing the
control and had formed crescents of inhibition around disks
containing samples with antifungal activity. The leguminous
defensin-like peptide sesquin was employed as a positive
control [18] and emperor banana lectin [37]a san e g a t i v e
control.6 Evidence-Based Complementary and Alternative Medicine
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Figure7:(a)Antiproliferativeeﬀectofmini-blacksoybeanprotease
inhibitor (
￿) and hemagglutinin (•) on MCF-7 cells. Results are
presented as means ± SD (n = 3). The inhibitor or lectin was
incubated with 2 × 10−3 MCF-7 cells in a 96-well plate for
72 hours prior to incubation with MTT for 4 hours. The plate
was centrifuged and the supernatant removed before addition
of DMSO to dissolve the MTT-formazan at the bottom of the
well. OD590nm was then measured after 10 minutes. Background
values were determined and subtracted before % inhibition values
were calculated. Data points bearing the same letter represent
statistically signiﬁcant diﬀerence (P<. 05) when the data were
analyzed by ANOVA followed by Duncan’s multiple range test. (b)
Antiproliferative eﬀect of mini-black soybean protease inhibitor
(
￿) and hemagglutinin (•) on HepG2 cells. Results are means ±
SD (n = 3). The inhibitor or the hemagglutinin was incubated
with 2 × 10−3 HepG2 cells in a 96-well plate for 72 hours prior
to incubation with MTT for 4 hours. The plate was centrifuged
and the supernatant removed before addition of DMSO to dissolve
the MTT-formazan at the bottom of the well. OD590nm was then
measured after 10 minutes. Background values were determined
and subtracted before % inhibition values were calculated. Data
points bearing the same letter represent statistically signiﬁcant
diﬀerence (P<. 05) when the data were analyzed by ANOVA
followed by Duncan’s multiple range test.
3.Results
3.1. Isolation of Protease-Inhibitor and Hemagglutinin. When
the extract of mini-black soybeans was chromatographed
on Q-Sepharose, trypsin-inhibitory activity, and hemagglu-
tinating activity resided in the adsorbed fraction eluted by
the linear concentration gradient of 0 to 0.2M NaCl, but
not in the unabsorbed fraction. This adsorbed fraction was
subsequently resolved on SP-Sepharose into an unabsorbed
fraction (devoid of trypsin-inhibitory and hemagglutinating
activities) and several adsorbed fractions, SP1, SP2, and
SP3. Trypsin-inhibitory activity was detected in the largest
adsorbed fraction SP1, and hemagglutinating activity was
found in fraction SP3 which was much smaller in size
(Figure 1(a)). Fraction SP1 was subsequentlyfractionated on
DEAE-cellulose into an inactive unabsorbed fraction and
two adsorbed fractions, D1 and D2 (Figure 1(b)). Trypsin-
inhibitory activity was located only in fraction D2, which
represented puriﬁed trypsin inhibitor. The molecular mass
of D2 as determined by gel ﬁltration on Superdex 75
was 17.5-kDa (Figure 2). There was a 47-fold puriﬁcation
of trypsin-inhibitory activity (Table 1). Hemagglutinating
activity was adsorbed on Q-Sepharose and eluted with 0.2M
NaCl in 20mM Tris-HCl buﬀer (pH 7.4). The fraction
was subsequently adsorbed on SP-Sepharose and eluted in
fraction SP3. Fraction SP3 appeared as a single peak upon
gel ﬁltration on Superdex 75. The peak had a molecularmass
of 25-kDa (Figure 2) and appeared as a single 25-kDa band
in SDS-PAGE (Figure 3). The puriﬁed protease inhibitor
demonstrated a molecular mass of 17.5-kDa in SDS-PAGE
(Figure 3). A summary of puriﬁcation of the hemagglutinin
is provided in Table 2. Figure 4 is a ﬂow chart illustrating the
scheme forconcurrentisolation ofthe proteaseinhibitorand
hemagglutinin.
3.2. N-Terminal Sequences of Trypsin Inhibitor and Lectin.
The data are shown in Table 3. Considerable homology to
their counterparts from soybean is observed.
3.3. Biological Activities of Protease Inhibitor and Hemagglu-
tinin. The isolated protease inhibitor inhibited trypsin with
an IC50 of 7.2 ± 0.5μM( m e a n± SD, n = 3) (Figure 5(a)),
and chymotrypsin with an IC50 of 8.8 ± 0.2μM( m e a n±
SD, n = 3) (Figure 5(a)). Dithiothreitol inhibited the
trypsin-inhibitory activityoftheproteaseinhibitorinadose-
dependent manner (Figure 5(b)). The trypsin-inhibitory
activity of the protease inhibitor and the hemagglutinating
activity of the lectin were stable from pH 2 to pH 13 (data
not shown). Activity was fully preserved from 0◦Ct o7 0 ◦C
for the protease inhibitor and from 0◦Ct o7 5 ◦Cf o rt h e
hemagglutinin (data not shown).
The protease inhibitor and the hemagglutinin inhibited
HIV-1 reverse transcriptase with an IC50 of 3.2 ± 0.2μM
and 5.5 ± 0.5μM( Figure 6), and suppressed proliferation
of MCF-7 breast cancer cells with an IC50 of 9.7 ± 0.3μM
and 3.5 ± 0.2μM( Figure 7(a)), and HepG2 hepatoma cells
with an IC50 of 35 ± 0.3μMa n d6 . 2± 0.3μM( Figure 7(b)),
respectively. The hemagglutinating activity of the hemagglu-
tinin was inhibited by sugars with the following ranking of
potencies: D(+) – raﬃnose = N-acetyl-D-galactosamine
￿
melibiose = L-arabinose >α -lactose > D(+)-glucosamine >
glucuronic acid > D(+)-fucose (Table 4).
Neither the protease inhibitor nor the hemagglutinin
demonstrated antifungal activity when tested up to 100μM
(data not shown). Biological activities which the isolatedEvidence-Based Complementary and Alternative Medicine 7
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Figure 8: Biologicalactivities of protease inhibitor and hemagglutininfrom mini-black soybean.
Table 1: Yields (from 50g beans) and trypsin-inhibitory activities of various chromatographic fractions obtained during diﬀerent steps of
puriﬁcation of mini-black soybean protease inhibitor.
Fraction Total protein
(mg)
Total trypsin-inhibitory
activity (u)
Speciﬁc trypsin-inhibitory
activity (u/mg)
Recovery oftrypsin-inhibitory
activity (%)
Fold of
puriﬁcation
Extract 9800 17640 1.8 100 1
Q 625 9375 15 53.1 8.3
SP1 242 8228 34 46.6 18.9
D2 53 4505 85 25.5 47.2
Table 2: Yields (from 50g beans) and hemagglutinating activities of various chromatographic fractions obtained during diﬀerent steps of
puriﬁcation of mini-black soybean hemagglutinin.HA: hemagglutinating.
Fraction Total protein
(mg)
Total HA activity
(u)
Speciﬁc HA activity
(u/mg)
Recovery of HA activity
(%)
Fold of
puriﬁcation
Extract 9800 87220 8.9 100 1
Q 625 30010 48 34.4 5.3
SP3 23 5888 256 6.8 28.8
S 18 5526 307 6.3 34.5
Table 3: N-terminal sequences of protease inhibitor and hemagglutinin from mini-black soybean.
Residue
number Sequence Residue
number
Kunitz-type trypsin inhibitor from
mini-black soybean (Glycine soja) 1 GFVLDNQGNPLQNGGTYYLLSDITAFGGIRAAPTGNERYPLTVVQS 47
Trypsin inhibitor subtype B from yellow
soybean (Glycine max) 1 DVLDNEGNPLQNGGTYYILSDITAFGGIRAAPTGNERYPLTVVQS 47
mini-black soybean hemagglutinin 1 AQTVSFSSWNKFVPKQPNILQGDAEVTSTGKLQLKAVKN 39
yellow soybean lectin 1 AETTSFSITK FVPDQKNLIFQGDAEVTSTGKLKLKAVKN 398 Evidence-Based Complementary and Alternative Medicine
Table 4:Eﬀectofvariouscarbohydrates onhemagglutinatingactivityofmini-blacksoybeanhemagglutinin.Initialhemagglutinatingactivity
was 3 hemagglutinating units, +: hemagglutination in presence of sugar, −: no hemagglutinationin presence of sugar.
Sugar (mM) 1.6 3.12 6.25 12.5 25 50 100 200
M e l i b i o s e + +++ −− − −
L - A r a b i n o s e + +++ −− − −
D ( + ) - G l u c o s a m i n e + +++ + + −−
Glucuronic acid + + + + + + −−
D ( + ) - X y l o s e + +++ + + + +
D-Galacturonic acid + + + + + + + +
α- L a c t o s e + +++ + −− −
D(+)-Raﬃnose −− − −− − −−
Mannitol + + + + + + + +
D(+)-Galactose + + + + + + + +
D - G l u c o s e + +++ + + + +
D ( + ) - F u c o s e + +++ + + −−
N-Acetyl-D-Galactosamine −− − −− − −−
D(+)-Mannose + + + + + + + +
Alpha-Methyl-D-Glucoside + + + + + + + +
D-Galactonic acid + + + + + + + +
M a l t o s e + +++ + + + +
D - L - R h a m n o s e + +++ + + + +
X y l i t o l + +++ + + + +
protease inhibitor and hemagglutinin have in common are
shown in Figure 8.
3.4.Comparison ofHemagglutinin and ProteaseInhibitor from
Mini-Black Soybean with Those from Soybean. The compar-
ison is shown in Tables 5 and 6.S o m ed i ﬀerences are noted
between proteins from the two cultivars of soybean.
4.Discussion
We report herein the concurrent puriﬁcation of a pro-
tease inhibitor and a hemagglutinin from the mini-black
soybean. Both proteins are adsorbed on Q-Sepharose and
SP-Sepharose but can be resolved from one another by
using a linear NaCl concentration (0–0.5M) gradient to
elute adsorbed proteins from the SP-Sepharose column. The
hemagglutinin is more strongly adsorbed on SP-Sepharose
than the protease inhibitor. It requires only two steps,
ion exchange chromatography on Q-Sepharose and SP-
Sepharose, to purify the hemagglutinin since it appears as a
single band in SDS-PAGE and a single peak in gel ﬁltration
after SP-Sepharose chromatography. In a previous investiga-
tion, simultaneous puriﬁcation of a protease inhibitor and
a hemagglutinin from Pseudostellaria heterophylla roots has
been achieved. Both the protease inhibitor and the lectin
are unabsorbed on DEAE-cellulose and adsorbed on CM-
cellulose. They can be separated from one another by gel
ﬁltration on Superdex 75 in which the 36-kDa lectin appears
as the ﬁrst peak and the 20.5-kDa protease inhibitor is eluted
as the second peak [38]. Similar to protease inhibitors from
o t h e rl e g u m i n o u ss e e d ss u c ha sb r o a db e a n[ 2], mini-black
soybean protease inhibitor is also a chymotrypsin inhibitor.
The ability of the reducing agent dithiothreitol to reduce the
trypsin-inhibitory activity of mini-black soybean protease
inhibitor in a dose-dependent manner, as in the case of
trypsin-inhibitor from papaya [8], revealed the importance
of disulﬁde bonds to the trypsin-inhibitory activity. The
ability of mini-black soybean protease inhibitor to inhibit
proliferation of hepatoma and breast cancer cells is in com-
pliancewithearlierreportsoftheantitumor/antiproliferative
activity ofleguminousprotease inhibitors[14–17].TheHIV-
1 reverse transcriptase inhibitory activity of the protease
inhibitor is also in agreement with previous ﬁndings on
trypsin inhibitors from the broad bean [2]an dwam pee[11].
However, it is noteworthy that some trypsin inhibitors like
those of lentil [9], Vigna mungo [39], and lily bulbs [40]
are devoid of antiproliferative activity toward tumor cells
and exhibit very weak or no HIV-1 reverse transcriptase
inhibitory activity. The mechanism of the inhibitory action
on the retroviral enzyme may be protein-protein interaction
[42–44]. HIV-1 protease inhibits the homologous reverse
transcriptase with this mechanism [44]. Unlike broad bean
trypsin inhibitor [2] but similar to those of lentil [9], Vigna
mungo [39], and lily bulbs [40] ,t h ep r o t e a s ei n h i b i t o r
isolated in the present study does not suppress mycelial
g r o w t h .I ti saK u n i t z - t y p et r y p s i ni n h i b i t o ra se v i d e n c e db y
its molecular mass and N-terminal sequence.
The hemagglutinin isolated in the present study is capa-
ble of potently inhibiting HIV-1 reverse transcriptase. Some
hemagglutininshavebeenshowntosuppressHIVreplication
[45] and reduce HIV infectivity [46] and infections [47]
while other hemagglutinins inhibit the retroviral reverse
transcriptase [48, 49]. The hemagglutinin also exerts itsEvidence-Based Complementary and Alternative Medicine 9
Table 5: Comparisonof lectins from diﬀerent cultivars of soybean.
Soybean lectin Chinese mini-black soybean hemagglutinin
Molecular weight 122kDa 25kDa
No. of subunits 4 1
Sugar speciﬁcity N-acetylgalactosamine D(+)-raﬃnose
pH stability pH 2–13 pH 2–13
Thermostability Up to 50◦CU p t o 7 5 ◦C
Antitumor activity Present HepG2 IC50:6 . 2μM
MCF-7 IC50:3 . 5μM
Inhibitory activity of HIV-1 reverse transcriptase Present IC50:5 . 5μM
Table 6: Comparison of trypsin inhibitors from diﬀerent cultivars of soybean.
Soybean trypsin inhibitor Chinese mini-black soybean Protease inhibitor
Molecular weight 20kDa 17.5kDa
Monomeric/with subunits Monomeric Monomeric
pH stability pH 3–13 pH 2–13
Thermostability Not done Up to 70◦C
Trypsin inhibitory activity IC50:7 . 2μMI C 50:8 . 8μM
Chymotrypsin inhibitory activity IC50:7 . 6μMI C 50:7 . 9μM
Inhibition of trypsin inhibitor by DTT (IC50) Lower than 10mM 30mM
potent antiproliferative activity against hepatoma HepG2
and breast cancer MCF-7 cells, the ﬁndings are in line
with previous reports on the antiproliferative/antitumor
activity of other hemagglutinins [17, 47–56]. Lectins and
lectin-containing extracts induceapoptosis [57]a n dr e g u l a t e
the expression of apoptotic genes in cancer cells [58, 59].
It is highly likely that mini-black soybean hemagglutinin
exerts its antitumor eﬀects on breast cancer MCF-7 cells
with a mechanism similar to that employed by French
bean hemagglutinin [58]. The hemagglutinin demonstrates
a higher antiproliferative activity on hepatoma and breast
cancercellsthantheproteaseinhibitor.However,itmanifests
a weaker HIV-1 reverse transcriptase inhibitory activity than
t h ep r o t e a s ei n h i b i t o r .
Results of the present investigation on a Chinese cultivar
of black soybean show some diﬀerences from earlier reports
on soybean trypsin inhibitor and soybean lectin. The early
ﬁndings were on a Bowman-Birk type trypsin inhibitor
with a molecular mass of about 8-kDa and a Kunitz-type
trypsin inhibitor with a molecular mass of about 21-kDa
[16]. However, only a single 17.5-kDa Kunitz-type inhibitor
wasfoundinthepresentstudy.Soybeanlectinreportedinthe
literatureisspeciﬁc forgalactose. The hemagglutininisolated
inthepresentstudyhas asugar speciﬁcitytowardbothD(+)-
raﬃnose and N-acetylgalactosamine. Bothproteaseinhibitor
and hemagglutinin isolated in the present study have potent
HIV-1 reverse transcriptase inhibitory and antiproliferative
activities with IC50 values mostly below 10μM. It appears
that mini-black soybean may have health promoting eﬀects.
The two proteins isolated in the present study are devoid
of antifungal activity. Some [2, 11]b u tn o to t h e r[ 9, 12]
protease inhibitors display antifungal activity. Similarly, to
date only a small number of hemagglutinins with antifungal
activity have been reported [60, 61].
Diﬀerent cultivars of the same plant species may pro-
duce diﬀerent proteins. For instance, diﬀerent cultivars of
the pea Pisum sativum produce the ribosome inactivating
protein pisavin [19] and the antifungal protein sativin [62],
respectively. Diﬀerentcultivars of the bean Phaseolusvulgaris
including the pinto bean, ﬂageolet bean, haricot bean,
French bean, and red kidney bean produce diﬀerent lectins
[63]. From the Japanese black soybean [64], a Bowman-
Birk trypsin inhibitor with antiproliferative activity but no
Kunitz-type trypsin inhibitor has been isolated. Both types
oftrypsin inhibitorare producedby the soybean [2] butonly
a Kunitz-type trypsin inhibitor is elaborated by the mini-
black soybean cultivar. The number and type of protease
inhibitor produced by soybean depend on the cultivar.
Hemagglutininsproducedbydiﬀerentsoybeancultivars may
also be diﬀerent. The results of the present investigation are
in line with the aforementioned observation.
Antiviral activity against two respiratory illness
viruses, human adenovirus type 1 and coxsackie virus
B1, has been demonstrated in a hot-water extract of
black soybean. In contrast, the hot-water extract of
common yellow soybean exhibited much lower activity.
Neither saponins nor anthocyanins account for the
antiviral activity. A partially puriﬁed hydrophilic and
anionic antiviral compound was obtained by gel ﬁltration,
reversed phase HPLC, and ion-exchange HPLC. It showed
maximum absorption at 260nm, indicating the presence
of phenyl groups. Amino acid analysis and neutral sugar
analysis disclosed that the antiviral compound is not
a protein or glycoconjugate with neutral sugars [65].10 Evidence-Based Complementary and Alternative Medicine
Anthocyanidins are possible anti-inﬂammatory agents;
however, further studies are required to determine required
intake levels in vivo to exert antitumor eﬀect [66]. The
anticancer therapeutic potential of soy isoﬂavone genistein
was reviewed by Ravindranath et al. [67].
The aforementioned investigations conducted by other
groupsrevealedtheantiviral andantitumor activities ofnon-
proteinaceous constituents of black soybean. The present
study demonstrated that protein components of black soy-
bean exhibit these activities.
Soybean trypsin inhibitor remains stable for 60 minutes
in simulated gastric ﬂuid. The bulk of soybean lectin is
digested within 8 minutes. The results on simulated gastric
ﬂuid diﬀer from those on simulated intestinal ﬂuid. Soybean
trypsin inhibitor, soybean lectin, and peanut lectin are stable
for 60 minutes in simulated intestinal ﬂuid [68]. The legume
lectin Griﬀonia simplicifolia lectin II [69] and banana lectin
[70] are trypsin-stable. Thus, it is likely that soybean trypsin
inhibitor and soybean lectin are relatively stable after passage
through the gastrointestinal tract.
In this investigation, a protease inhibitor and a hemag-
glutinin, with some diﬀerences in characteristics from soy-
bean trypsin inhibitor and soybean lectin reported earlier,
have been isolated using some protocol from a Chinese
cultivar of soybean, the mini-black soybean. In traditional
Chinese medicine, black soybean is more nutritious and
reinvigorating than soybean. The ﬁnding of a hemagglutinin
and a protease inhibitor from black soybean, both with
relatively stable medicinal activities including HIV-1 reverse
transcriptase inhibitory and antiproliferative activities, at
least partially account for its use in traditional Chinese
medicine.
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